GlassScriptPhysician profile
Russell Reeves
NPI 1740279348
$23,320.72
in general payments reported to CMS, 2019-2025
11 companies · $384 in 2025
The $384 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,852 · 2020: $1,318 · 2021: $2,641 · 2022: $9,106 · 2023: $2,466 · 2024: $4,554 · 2025: $384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,750 · Food and Beverage: $1,650 · Travel and Lodging: $3.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,750.00 |
| Food and Beverage | $1,650.19 |
| Travel and Lodging | $3.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $18,589.29 | 2019-2025 | Farapulse, Watchman Access System, General - Therapies |
| Philips North America LLC | $2,112.30 | 2019-2022 | |
| Medtronic, INC. | $694.32 | 2022-2024 | Cobalt Dr Mri Surescan, Micra, Attain Command + Surevalve |
| Medtronic Vascular, INC. | $608.35 | 2019 | |
| Cook Medical LLC | $492.33 | 2020-2023 | Evolution |
| Novartis Pharmaceuticals Corporation | $388.64 | 2023-2025 | |
| Abbott Laboratories | $230.08 | 2019-2024 | Cardiomems, Jot Dx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $139.03 | 2019-2025 | Lifevest |
| Cvrx, INC. | $66.38 | 2021 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Russell Reeves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.